Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Tocris Bioscience™ GSK 2606414

Potent and selective PERK inhibitor; orally bioavailable

Supplier: Tocris Bioscience™ 5107/10

View more versions of this product

Catalog No. 51-071-0

$442.50 / Each of 1

Qty

Add to Cart

This item is not returnable. View return policy

Description

GSK 2606414 is a potent and selective protein kinase R-like ER kinase (PERK) inhibitor (IC50 = 0.4 nM). Exhibits >1000-fold selectivity for PERK over HR1 and PKR. Inhibits thapsigargin-induced PERK phosphorylation in lung carcinoma A549 cells. Attenuates subcutaneous pancreatic human tumor xenograft growth in mice. Orally bioavailable.

Specifications

Purity	>99%
Product Type	GSK 2606414
Inhibitors	GSK 2606414

Quantity	10 mg
Molecular Weight (g/mol)	451.44

Product Suggestions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

Your Name

Email Address *

Type of Issue *

Detailed Description of Issue/Request *

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

Your feedback has been submitted: Thank you for helping us improve our website.

For Research Use Only

Spot an opportunity for improvement?Share a Content Correction

Tocris Bioscience™ GSK 2606414

Description

Specifications

Product Suggestions

Documents

Promotions